Prashant Patil
About Prashant Patil
Prashant Patil is a Manager at Procter & Gamble and Merck Group, specializing in formulation development and tech transfer in the pharmaceutical industry.
Professional Experience at Procter & Gamble
Prashant Patil is currently serving as Manager - FnD, TT at Procter & Gamble, since 2018. Based in the Mumbai Area, India, he brings extensive expertise in pharmaceutical development to his role. His duties include overseeing formulation development, technology transfer, and process validation. His skills in generating critical documents such as MFR, SOP, protocols, and reports are pivotal to his work.
Professional Experience at Merck Group
Prashant Patil has been working at Merck Group since 2016 as Manager - FnD & TT in the Mumbai Area, India. His responsibilities encompass formulation development, the technology transfer of pharmaceutical products, and ensuring adherence to quality standards. Prashant has a significant background in stability studies following ICH guidelines, enhancing Merck Group’s R&D capabilities.
Educational Background and Degrees
Prashant Patil obtained his Master’s Degree in Pharmaceuticals from the Rajasthan University of Health Sciences between 2013 and 2016. He also holds a B. Pharmacy degree from the Government College of Pharmacy, Karad, Maharashtra, earned between 1989 and 1993. Additionally, he has a Diploma in Business Management from IBMR Pune University.
Experience at Franco Indian Pharma
Prashant Patil worked as a Senior Executive in Research & Development & TT at Franco Indian Pharma in Mumbai from 2005 to 2007. During this period, he focused on the formulation development and tech transfer of pharmaceutical products, contributing significantly to the company's product pipeline.
Skills and Specializations
Prashant Patil possesses specialized skills in the formulation development of nasal preparations and injectables. He is adept at tech transfer, process validation, and troubleshooting in pharmaceutical production. Additionally, he has a strong background in the development of solid dosage forms, including tablets and capsules. His expertise extends to generating critical documents such as MFR, SOP, protocols, reports, and dossiers.